Jazz Pharmaceuticals CEO Russell Cox Resigned

Daniel Swisher leaves an ailing Sunesis and swoops in to lead Jazz Pharmaceuticals

Daniel Swisher, the CEO of the struggling Sunesis Pharmaceuticals, has been recruited to global biopharma Jazz Pharmaceuticals as the company’s new president and chief operations officer. Swisher is taking over the spot from Russell Cox, who’s resigned from the Dublin company to lead an unnamed biopharmaceutical company working in liver

Name: Russell Cox

Continent: North America

Country: USA

Company: Jazz Pharmaceuticals

Branch: Pharma

Position: CEO

Reason: Resigned

Announcement Date: December 04, 2017, 11:00pm

Resignation Date: December 04, 2017, 11:00pm

Source 1: https://endpts.com/daniel-swisher-leaves-an-ailing-sunesis-and-swoops-in-to-lead-jazz-pharmaceuticals/